Gilbert & Cook, Inc.
- SEC CIK
- 0001675762
- Latest filing
- Jul 28, 2026
REGN holding history
Regeneron Pharmaceuticals, Inc. in every 13F filed by Gilbert & Cook, Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
REGN overviewAll 13F holders of REGNFull Q2 2026 holdings
- Shares (Q2 2026)
- 0
- Sold out in Q2 2026
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 12
- Since Q2 2023
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 0 | $0 | 0.0% | −1,695−100.0% | Sold out | Holders |
| Q1 2026 | 1,695 | $1.31M | 0.2% | −14−0.8% | Reduced | Holders |
| Q4 2025 | 1,709 | $1.32M | 0.2% | −25−1.4% | Reduced | Holders |
| Q3 2025 | 1,734 | $975.0K | 0.1% | −3−0.2% | Reduced | Holders |
| Q2 2025 | 1,737 | $911.9K | 0.1% | +34+2.0% | Added | Holders |
| Q1 2025 | 1,703 | $1.08M | 0.2% | +3+0.2% | Added | Holders |
| Q4 2024 | 1,700 | $1.21M | 0.2% | −5−0.3% | Reduced | Holders |
| Q3 2024 | 1,705 | $1.79M | 0.2% | −45−2.6% | Reduced | Holders |
| Q2 2024 | 1,750 | $1.84M | 0.3% | −182−9.4% | Reduced | Holders |
| Q1 2024 | 1,932 | $1.86M | 0.3% | +25+1.3% | Added | Holders |
| Q4 2023 | 1,907 | $1.67M | 0.2% | +146+8.3% | Added | Holders |
| Q3 2023 | 1,761 | $1.45M | 0.2% | +1,182+204.1% | Added | Holders |
| Q2 2023 | 579 | $416.0K | 0.1% | +579 | New | Holders |